TNKase (T-N-Kase, tenecteplase), a new thrombolytic for acute MIs

July 2000

Genentech is now introducing TNKase (T-N-Kase, tenecteplase), a new thrombolytic for acute MIs.

TNKase is a modified version of Activase (alteplase, tPA). It's made by substituting 3 amino acids of the tPA enzyme.

TNKase and Activase have comparable efficacy for restoring blood flow and improving survival after an MI.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote